Hauck & Aufhaeuser set a €110.00 ($127.91) target price on Carl Zeiss Meditec (ETR:AFX) in a research note released on Friday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
Other research analysts have also recently issued research reports about the company. Kepler Capital Markets set a €80.00 ($93.02) target price on Carl Zeiss Meditec and gave the company a sell rating in a research note on Friday, December 6th. Deutsche Bank set a €140.00 ($162.79) price objective on Carl Zeiss Meditec and gave the company a buy rating in a research note on Thursday, January 23rd. Nord/LB set a €132.00 ($153.49) price objective on Carl Zeiss Meditec and gave the company a buy rating in a research note on Wednesday, December 11th. Independent Research set a €93.00 ($108.14) price objective on Carl Zeiss Meditec and gave the company a sell rating in a research note on Tuesday, December 10th. Finally, HSBC set a €109.00 ($126.74) price objective on Carl Zeiss Meditec and gave the company a neutral rating in a research note on Tuesday, December 10th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of €111.14 ($129.24).
AFX opened at €111.40 ($129.53) on Friday. The stock has a market cap of $9.96 billion and a PE ratio of 62.37. The company has a quick ratio of 3.01, a current ratio of 3.84 and a debt-to-equity ratio of 4.06. Carl Zeiss Meditec has a 52 week low of €71.25 ($82.85) and a 52 week high of €122.10 ($141.98). The business’s fifty day simple moving average is €116.24 and its 200 day simple moving average is €105.70.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Further Reading: What is a dividend reinvestment plan?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.